CA1338083C - Ozonides de terpenes et leur utilisation medicale - Google Patents

Ozonides de terpenes et leur utilisation medicale

Info

Publication number
CA1338083C
CA1338083C CA000603585A CA603585A CA1338083C CA 1338083 C CA1338083 C CA 1338083C CA 000603585 A CA000603585 A CA 000603585A CA 603585 A CA603585 A CA 603585A CA 1338083 C CA1338083 C CA 1338083C
Authority
CA
Canada
Prior art keywords
terpene
composition
ozonide
ozonides
pharmaceutical composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000603585A
Other languages
English (en)
Inventor
Stephen Herman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of CA1338083C publication Critical patent/CA1338083C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D323/00—Heterocyclic compounds containing more than two oxygen atoms as the only ring hetero atoms
    • C07D323/02—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CA000603585A 1988-06-24 1989-06-22 Ozonides de terpenes et leur utilisation medicale Expired - Fee Related CA1338083C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21137888A 1988-06-24 1988-06-24
US211,378 1988-06-24

Publications (1)

Publication Number Publication Date
CA1338083C true CA1338083C (fr) 1996-02-27

Family

ID=22786691

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000603585A Expired - Fee Related CA1338083C (fr) 1988-06-24 1989-06-22 Ozonides de terpenes et leur utilisation medicale

Country Status (5)

Country Link
EP (1) EP0427781A4 (fr)
JP (1) JPH04502145A (fr)
AU (1) AU4058689A (fr)
CA (1) CA1338083C (fr)
WO (1) WO1989012626A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4983637A (en) * 1988-06-24 1991-01-08 Stephen Herman Method for treating viral infection of HIV
US5270344A (en) * 1988-06-24 1993-12-14 Stephen Herman Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5364879A (en) * 1988-06-24 1994-11-15 Cliveden Ltd. Medical uses of trioxolane and diperoxide compounds
JPH03170422A (ja) * 1989-11-22 1991-07-24 Dermatologic Res Corp 皮膚疾患の治療法
US5153229A (en) * 1990-06-01 1992-10-06 Doyle E. Chastain Process for producing reference bactericidal endpoint (RBE) limonene
AUPM493194A0 (en) * 1994-04-08 1994-05-05 Buckmeier, Julie A. Therapeutic agent for inhibiting the conversion of epithelial cells to tumours
WO1998000168A1 (fr) * 1996-07-02 1998-01-08 Novartis Consumer Health S.A. Composition topique contenant une combinaison de composes antihistaminiques et de composes terpenoides
CA2566180A1 (fr) * 2004-05-10 2005-11-24 Robert F. Hofmann Utilisation d'une formulation therapeutique oxydative ciblee dans le traitement du cancer
JPWO2008001553A1 (ja) * 2006-06-28 2009-11-26 株式会社Ｅｒｃテクノロジー オゾン化界面活性剤
JP2011507969A (ja) * 2007-12-27 2011-03-10 タイラテック， インク． 相乗的抗寄生虫組成物とスクリーニング方法
KR101698051B1 (ko) * 2016-01-13 2017-01-20 아주대학교산학협력단 로가닌 또는 이의 유도체를 유효성분으로 함유하는 여성 갱년기 증후군 예방, 개선 또는 치료용 조성물
CN108210490A (zh) * 2018-04-10 2018-06-29 武汉大学 一种雌激素受体下调剂的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US925590A (en) * 1902-07-05 1909-06-22 Oxoline Company Process of producing a medicament.
US1210949A (en) * 1914-07-30 1917-01-02 Gen Res Lab Medicinal compound.
US2083572A (en) * 1928-04-25 1937-06-15 Susan M Mckee Process of treating oil
US2243053A (en) * 1931-08-30 1941-05-20 Alexander S Ramage Process for manufacturing oxygen compounds of terpene hydrocarbons
US2356062A (en) * 1942-02-03 1944-08-15 Latimer Lab Inc Therapeutic composition
US3504038A (en) * 1966-06-24 1970-03-31 Us Agriculture Ozonization of vegetable oils in an improved aqueous medium
US4163800A (en) * 1977-08-17 1979-08-07 The Procter & Gamble Company Topical composition and treatment of skin lesions therewith
US4591602A (en) * 1982-04-16 1986-05-27 James H. Brown Ozonide esters and topical compositions containing same
US4451480A (en) * 1982-04-16 1984-05-29 James Howard Brown Method of treating acne using ozonized materials

Also Published As

Publication number Publication date
WO1989012626A1 (fr) 1989-12-28
EP0427781A4 (en) 1991-08-21
JPH04502145A (ja) 1992-04-16
AU4058689A (en) 1990-01-12
EP0427781A1 (fr) 1991-05-22

Similar Documents

Publication Publication Date Title
US5190979A (en) Ozonides of terpenes and their medical uses
US5270344A (en) Method of treating a systemic disorder using trioxolane and diperoxide compounds
US5364879A (en) Medical uses of trioxolane and diperoxide compounds
US4983637A (en) Method for treating viral infection of HIV
US5126376A (en) Method for treating viral infection using topical administration
US5260342A (en) Method for treating viral infection parenterally
CA1338083C (fr) Ozonides de terpenes et leur utilisation medicale
US5190977A (en) Antiviral compositions
MXPA04009712A (es) Procedimiento para la obtencion de aceites y grasas vegetales ozonizados y aplicacion de estos productos con fines farmaceuticos y cosmetologicos.
DE3310079A1 (de) Topische ophthalmische arzneimittel
EA003741B1 (ru) Местное трансдермальное лечение
JPH0216728B2 (fr)
DE69907193T2 (de) Vitamin e und seine ester zur verwendung in der lokale behandlung von schleimhauterkrankungen
EA017660B1 (ru) Гель, обладающий противовоспалительным и противоаллергическим действием
US5086076A (en) Antiviral pharmaceutical compositions comprising a terpene ozonide
US4626530A (en) Treatment of eye inflammation with biphenamine
DE69002946T2 (de) Paracetamol enthaltende arzneizubereitung.
US5071879A (en) Systemic antiviral treatment
US6406706B1 (en) Use of α- and β-santalols major constituents of sandal wood oil, in the treatment of warts, skin blemishes and other viral-induced tumors
DK2343038T3 (en) Dermatological compositions containing a combination of peroxidized lipids and zinc and their use, especially for the treatment of herpes
CA2126757A1 (fr) Utilisation de composes trioxolane et diperoxyde en medecine
US5070107A (en) Systemic antiviral treatment
US3812250A (en) Antifungal suppository and method of treating fungus infestations
MXPA01003507A (es) Antimicrobiano sinergico, preparaciones dermatologicas y oftalmicas que contienen clorito y peroxido de hidrogeno.
US4147785A (en) Method for the treatment of onchocerciasis

Legal Events

Date Code Title Description
MKLA Lapsed